X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Rheumatoid Arthritis Diagnostic Tests Companies

This report lists the top Rheumatoid Arthritis Diagnostic Tests companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Rheumatoid Arthritis Diagnostic Tests industry.

Rheumatoid Arthritis Diagnostic Tests Top Companies

  1. Abbott Laboratories

  2. Siemens Healthineers AG

  3. Thermo Fisher Scientific Inc.

  4. Augurex Life Sciences Corp.

  5. Danaher Corporation (Beckman Coulter)

*Disclaimer: Top companies sorted in no particular order

 Rheumatoid Arthritis Diagnostic Tests Market Major Players

Rheumatoid Arthritis Diagnostic Tests Market Concentration

Rheumatoid Arthritis Diagnostic Tests Market Concentration

Rheumatoid Arthritis Diagnostic Tests Company List

                              • Abbott Laboratories

                              • Siemens Healthineers AG

                              • Thermo Fisher Scientific Inc.

                              • Exagen Inc.

                              • Svar Life Science

                              • Augurex Life Sciences Corp.

                              • Danaher Corporation (Beckman Coulter)

                              • Biopanda Reagents Ltd.

                              • Bio-Rad Laboratories, Inc.

                              • Tulip Diagnostics (P) Ltd

                              • Boditech Med Inc.

                              • Getein Biotech, Inc.


                          Specific to Rheumatoid Arthritis Diagnostic Tests Market
                          Need More Details On Market Players And Competitors?
                          Download Sample

                          Rheumatoid Arthritis Diagnostic Tests Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)